Anpario (LON:ANP) PT Raised to GBX 370 at Canaccord Genuity Group

Anpario (LON:ANPFree Report) had its target price hoisted by Canaccord Genuity Group from GBX 340 ($4.49) to GBX 370 ($4.89) in a research report report published on Wednesday morning, MarketBeat.com reports. They currently have a buy rating on the stock.

Separately, Shore Capital reiterated a house stock rating on shares of Anpario in a research note on Wednesday, September 11th.

Check Out Our Latest Stock Report on ANP

Anpario Price Performance

Shares of LON:ANP opened at GBX 312.50 ($4.13) on Wednesday. The company has a current ratio of 5.13, a quick ratio of 5.16 and a debt-to-equity ratio of 0.23. Anpario has a twelve month low of GBX 220 ($2.91) and a twelve month high of GBX 340 ($4.49). The company’s 50 day moving average is GBX 288.06 and its 200 day moving average is GBX 274.76. The company has a market cap of £52.84 million, a PE ratio of 1,736.11 and a beta of 0.57.

Anpario Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Friday, November 29th. Stockholders of record on Thursday, November 14th will be issued a GBX 3.25 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a dividend yield of 1.19%. Anpario’s dividend payout ratio (DPR) is presently 6,111.11%.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.